A. Gaw

1.6k total citations
38 papers, 883 citations indexed

About

A. Gaw is a scholar working on Surgery, Physiology and Economics and Econometrics. According to data from OpenAlex, A. Gaw has authored 38 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 7 papers in Physiology and 7 papers in Economics and Econometrics. Recurrent topics in A. Gaw's work include Lipoproteins and Cardiovascular Health (17 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). A. Gaw is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). A. Gaw collaborates with scholars based in United Kingdom, Hungary and Canada. A. Gaw's co-authors include J. Shepherd, P.P.A. Humphrey, John A. Bevan, Muriel Caslake, Bruce A. Griffin, Chris J. Packard, G.M. Lindsay, R. M. Wadsworth, A R Lorimer and David Nicholls and has published in prestigious journals such as Journal of Biological Chemistry, Brain and Stroke.

In The Last Decade

A. Gaw

38 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gaw United Kingdom 16 297 203 186 179 159 38 883
Sarah R. Bujac United Kingdom 15 246 0.8× 161 0.8× 187 1.0× 248 1.4× 150 0.9× 18 930
Simona Vuletic United States 17 245 0.8× 120 0.6× 217 1.2× 290 1.6× 78 0.5× 24 792
Michael Morcos Germany 19 137 0.5× 241 1.2× 215 1.2× 239 1.3× 142 0.9× 42 994
Kenneth B. Pomerantz United States 19 261 0.9× 253 1.2× 222 1.2× 361 2.0× 149 0.9× 37 1.2k
Stefania Di Mauro Italy 18 177 0.6× 203 1.0× 122 0.7× 389 2.2× 87 0.5× 48 1.1k
Stephanie Siu Canada 10 141 0.5× 164 0.8× 140 0.8× 220 1.2× 116 0.7× 13 1.3k
Bradley J. Davis United States 17 118 0.4× 157 0.8× 133 0.7× 418 2.3× 100 0.6× 34 1.1k
Kate Maclagan United Kingdom 11 146 0.5× 315 1.6× 143 0.8× 288 1.6× 262 1.6× 15 2.6k
Kenji Mizuno Japan 16 248 0.8× 227 1.1× 110 0.6× 302 1.7× 282 1.8× 82 867
Andrea Baessler Germany 20 187 0.6× 124 0.6× 219 1.2× 330 1.8× 345 2.2× 53 1.1k

Countries citing papers authored by A. Gaw

Since Specialization
Citations

This map shows the geographic impact of A. Gaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gaw more than expected).

Fields of papers citing papers by A. Gaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gaw. The network helps show where A. Gaw may publish in the future.

Co-authorship network of co-authors of A. Gaw

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gaw. A scholar is included among the top collaborators of A. Gaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gaw. A. Gaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Austin, Rupert P., Roger V. Bonnert, Anthony R. Cook, et al.. (2015). Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 25(7). 1616–1620. 16 indexed citations
2.
Gaw, A.. (2015). ‘The principles of a future pharmacology’: Johann Christian Reil (1759–1813) and his role in the development of clinical pharmacology. European Journal of Clinical Pharmacology. 72(1). 13–17. 1 indexed citations
3.
Nicholls, David, et al.. (2015). Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist. Journal of Pharmacology and Experimental Therapeutics. 353(2). 340–350. 67 indexed citations
4.
Casaburi, Richard, Bartolomé R. Celli, James D. Crapo, et al.. (2013). The COPD Biomarker Qualification Consortium (CBQC). COPD Journal of Chronic Obstructive Pulmonary Disease. 10(3). 367–377. 52 indexed citations
5.
Trompet, Stella, Anton J.M. de Craen, P. Eline Slagboom, et al.. (2008). Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study. Experimental Gerontology. 43(8). 801–805. 7 indexed citations
6.
Trompet, Stella, Anton J.M. de Craen, P. Eline Slagboom, et al.. (2008). Genetic variation in the interleukin-1 -converting enzyme associates with cognitive function. The PROSPER study. Brain. 131(4). 1069–1077. 56 indexed citations
7.
Nicholls, David, Katherine Wiley, Caroline Grahames, et al.. (2008). Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2. Molecular Pharmacology. 74(5). 1193–1202. 67 indexed citations
8.
9.
Gaw, A.. (2004). The care gap: underuse of statin therapy in the elderly. International Journal of Clinical Practice. 58(8). 777–785. 20 indexed citations
10.
Gaw, A., et al.. (2002). Are we negating the benefits of CABG by forgetting secondary prevention?. Journal of Human Hypertension. 16(10). 691–697. 15 indexed citations
11.
Buckley, Katherine M., Simon C. Wagstaff, A. Gaw, et al.. (2001). Parathyroid Hormone Potentiates Nucleotide-induced [Ca2+] Release in Rat Osteoblasts Independently of Gq Activation or Cyclic Monophosphate Accumulation. Journal of Biological Chemistry. 276(12). 9565–9571. 61 indexed citations
12.
Gaw, A.. (2001). Healthy ageing: addressing acute coronary syndrome?. European Heart Journal Supplements. 3. N11–N15. 2 indexed citations
13.
14.
Gaw, A., et al.. (1995). Role of pepsin in the development of indomethacin‐induced antral ulceration in the rat. Alimentary Pharmacology & Therapeutics. 9(2). 167–172. 11 indexed citations
15.
Gaw, A., et al.. (1995). Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK‐8 in the pithed rat. British Journal of Pharmacology. 115(4). 660–664. 19 indexed citations
16.
Griffin, Bruce A., et al.. (1992). Effects of cholestyramine and acipimox on subf ractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects. European Journal of Clinical Investigation. 22(6). 383–390. 13 indexed citations
17.
Gaw, A., J. Aberdeen, P.P.A. Humphrey, R. M. Wadsworth, & Geoffrey Burnstock. (1991). Relaxation of sheep cerebral arteries by vasoactive intestinal polypeptide and neurogenic stimulation: inhibition byl‐NG‐monomethyl arginine in endothelium‐denuded vessels. British Journal of Pharmacology. 102(3). 567–572. 71 indexed citations
18.
Gaw, A., Roger M. Wadsworth, & P.P.A. Humphrey. (1990). Pharmacological characterisation of postjunctional 5-HT receptors in cerebral arteries from the sheep. European Journal of Pharmacology. 179(1-2). 35–44. 22 indexed citations
19.
Gaw, A., Roger M. Wadsworth, & P.P.A. Humphrey. (1990). Neurotransmission in the Sheep Middle Cerebral Artery: Modulation of Responses by 5-HT and Haemolysate. Journal of Cerebral Blood Flow & Metabolism. 10(3). 409–416. 9 indexed citations
20.
Gaw, A. & R. M. Wadsworth. (1989). Pharmacological characterization of postjunctional α‐adrenoceptors in cerebral arteries from the sheep. British Journal of Pharmacology. 98(3). 741–746. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah R. Bujac Breakdown of academic impact, for papers by Simona Vuletic Breakdown of academic impact, for papers by Michael Morcos Breakdown of academic impact, for papers by Kenneth B. Pomerantz Breakdown of academic impact, for papers by Stefania Di Mauro Breakdown of academic impact, for papers by Stephanie Siu Breakdown of academic impact, for papers by Bradley J. Davis Breakdown of academic impact, for papers by Kate Maclagan Breakdown of academic impact, for papers by Kenji Mizuno Breakdown of academic impact, for papers by Andrea Baessler
Rankless by CCL
2026